Woodline Partners LP 13D/13G Filings for OKYO Pharma Limited (OKYO)

Woodline Partners LP 13D and 13G filings for OKYO Pharma Limited:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-15
09:01 am
Purchase
2026-03-3113GOKYO PHARMA LTD SHS USD
OKYO
Woodline Partners LP3,652,190
7.000%
3,652,190increase
(New Position)
Filing